DEERFIELD MANAGEMENT COMPANY, L.P. Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$5.6B
Holdings
143
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (143 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VTRSVIATRIS INC | 18,824,000 | $269.0B | 4778.17% | |
| 2 | —SINGULAR GENOMICS SYSTEMS IN | 9,112,019 | $250.4B | 4447.83% | |
| 3 | —INVITAE CORP | 163,385,000 | $221.7B | 3937.46% | |
| 4 | —CAREMAX INC | 16,778,750 | $216.4B | 3844.74% | |
| 5 | AHCOADAPTHEALTH CORP | 7,353,792 | $201.6B | 3580.44% | |
| 6 | —AERIE PHARMACEUTICALS INC | 157,390,000 | $156.6B | 2781.90% | |
| 7 | GKOS 2.75 06/15/27GLAUKOS CORP | 90,000,000 | $153.5B | 2727.23% | |
| 8 | NTRA 2.25 05/01/27NATERA INC | 45,000,000 | $136.3B | 2421.26% | |
| 9 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 80,000,000 | $131.2B | 2331.24% | |
| 10 | ORGOORGANOGENESIS HLDGS INC | 7,222,127 | $120.0B | 2132.13% | |
| 11 | NVST 2.375 06/01/25ENVISTA HOLDINGS CORPORATION | 52,500,000 | $112.0B | 1989.78% | |
| 12 | GMED 1 06/01/23NUVASIVE INC | 96,966,000 | $101.3B | 1799.36% | |
| 13 | EWTXEDGEWISE THERAPEUTICS INC | 3,933,137 | $83.9B | 1490.21% | |
| 14 | LUNGPULMONX CORP | 1,800,887 | $79.5B | 1411.36% | |
| 15 | PODD 0.375 09/01/26INSULET CORP | 57,581,000 | $78.2B | 1388.75% | |
| 16 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 41,825,000 | $77.8B | 1381.41% | |
| 17 | AFIBACUTUS MED INC | 4,341,799 | $73.7B | 1309.56% | |
| 18 | CNCCENTENE CORP DEL | 995,000 | $72.6B | 1288.97% | |
| 19 | NBIXNEUROCRINE BIOSCIENCES INC | 725,000 | $70.6B | 1253.31% | |
| 20 | PCRXPACIRA BIOSCIENCES INC | 1,147,000 | $69.6B | 1236.31% | |
| 21 | PTGXPROTAGONIST THERAPEUTICS INC | 1,362,790 | $61.2B | 1086.42% | |
| 22 | MIRMMIRUM PHARMACEUTICALS INC | 3,448,912 | $59.6B | 1059.25% | |
| 23 | MOHMOLINA HEALTHCARE INC | 231,776 | $58.7B | 1041.86% | |
| 24 | LRMRLARIMAR THERAPEUTICS INC | 5,830,249 | $57.3B | 1016.99% | |
| 25 | INSM 0.75 06/01/28INSMED INC | 50,000,000 | $55.5B | 986.24% | |
| 26 | SILKSILK RD MED INC | 1,138,525 | $54.5B | 967.91% | |
| 27 | ZBHZIMMER BIOMET HOLDINGS INC | 338,000 | $54.4B | 965.55% | |
| 28 | —CONSTELLATION PHARMCETICLS I | 1,601,427 | $54.1B | 961.48% | |
| 29 | INSM 1.75 01/15/25INSMED INC | 50,000,000 | $52.5B | 933.00% | |
| 30 | QDELUSDQUIDEL CORP | 409,219 | $52.4B | 931.30% | |
| 31 | ATECALPHATEC HLDGS INC | 3,402,384 | $52.1B | 925.90% | |
| 32 | —INTERCEPT PHARMACEUTICALS IN | 57,791,000 | $51.9B | 922.26% | |
| 33 | KALVKALVISTA PHARMACEUTICALS INC | 2,163,554 | $51.8B | 920.82% | |
| 34 | —DFP HEALTHCARE ACQUISITNS CO | 5,000,000 | $49.8B | 883.71% | |
| 35 | RVMDREVOLUTION MEDICINES INC | 1,565,712 | $49.7B | 882.75% | |
| 36 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,343,560 | $49.2B | 873.73% | |
| 37 | —CLOVIS ONCOLOGY INC | 49,064,000 | $47.8B | 849.23% | |
| 38 | SWTXSPRINGWORKS THERAPEUTICS INC | 558,574 | $46.0B | 817.67% | |
| 39 | —TABULA RASA HEALTHCARE INC | 45,000,000 | $45.6B | 810.71% | |
| 40 | GLPGGALAPAGOS NV | 657,005 | $45.3B | 803.97% | |
| 41 | BCRXBIOCRYST PHARMACEUTICALS INC | 2,835,000 | $44.8B | 796.16% | |
| 42 | NVAX 3.75 02/01/23NOVAVAX INC | 25,000,000 | $44.6B | 793.07% | |
| 43 | HOWLWEREWOLF THERAPEUTICS INC | 2,552,787 | $44.5B | 790.83% | |
| 44 | —APRIA INC | 1,572,892 | $44.0B | 782.30% | |
| 45 | —ONCORUS INC | 3,148,977 | $43.5B | 771.91% | |
| 46 | RETAEURREATA PHARMACEUTICALS INC | 300,000 | $42.5B | 754.20% | |
| 47 | ACHOWENS & MINOR INC NEW | 996,500 | $42.2B | 749.28% | |
| 48 | GMED 0.375 03/15/25NUVASIVE INC | 40,000,000 | $39.6B | 704.11% | |
| 49 | RYTMRHYTHM PHARMACEUTICALS INC | 1,989,625 | $39.0B | 691.99% | |
| 50 | KURAKURA ONCOLOGY INC | 1,794,000 | $37.4B | 664.43% | |
| 51 | INZYINOZYME PHARMA INC | 2,178,985 | $37.1B | 659.54% | |
| 52 | OPHTEURIVERIC BIO INC | 5,767,409 | $36.4B | 646.43% | |
| 53 | PBYIPUMA BIOTECHNOLOGY INC | 3,769,795 | $34.6B | 614.73% | |
| 54 | —BIODELIVERY SCIENCES INTL IN | 9,530,000 | $34.1B | 606.02% | |
| 55 | NUVBNUVATION BIO INC | 3,577,233 | $33.3B | 591.58% | |
| 56 | WVEWAVE LIFE SCIENCES LTD | 4,829,069 | $32.2B | 571.29% | |
| 57 | MR4MERIDIAN BIOSCIENCE INC | 1,424,274 | $31.6B | 561.13% | |
| 58 | ORTXUSDORCHARD THERAPEUTICS PLC | 6,949,416 | $30.5B | 541.91% | |
| 59 | ARDXARDELYX INC | 3,811,554 | $28.9B | 513.21% | |
| 60 | TERNTERNS PHARMACEUTICALS INC | 2,345,959 | $28.8B | 510.88% | |
| 61 | HCAT 2.5 04/15/25HEALTH CATALYST INC | 15,000,000 | $28.7B | 510.51% | |
| 62 | —GRAYBUG VISION INC | 5,281,713 | $28.7B | 509.44% | |
| 63 | XERS 5 07/15/25XERIS PHARMACEUTICALS INC | 18,000,000 | $28.5B | 507.05% | |
| 64 | AM6AMICUS THERAPEUTICS INC | 2,941,492 | $28.4B | 503.69% | |
| 65 | —ITAMAR MED LTD | 1,193,803 | $28.1B | 499.39% | |
| 66 | GRPHGRAPHITE BIO INC | 906,308 | $27.9B | 494.72% | |
| 67 | XLRNACCELERON PHARMA INC | 219,500 | $27.5B | 489.28% | |
| 68 | PMVPPMV PHARMACEUTICALS INC | 804,000 | $27.5B | 487.86% | |
| 69 | CGEMCULLINAN ONCOLOGY INC | 1,044,000 | $26.9B | 477.52% | |
| 70 | —XERIS PHARMACEUTICALS INC | 6,553,398 | $26.7B | 473.78% | |
| 71 | FATEFATE THERAPEUTICS INC | 304,000 | $26.4B | 468.66% | |
| 72 | B7SBROOKDALE SR LIVING INC | 3,298,000 | $26.1B | 462.80% | |
| 73 | 2L9BLUEPRINT MEDICINES CORP | 281,754 | $24.8B | 440.22% | |
| 74 | AVAHAVEANNA HEALTHCARE HLDGS INC | 2,000,000 | $24.7B | 439.46% | |
| 75 | CYTKCYTOKINETICS INC | 1,238,083 | $24.5B | 435.23% | |
| 76 | —BRIGHT HEALTH GROUP INC | 1,400,000 | $24.0B | 426.74% | |
| 77 | —KINNATE BIOPHARMA INC | 1,020,000 | $23.7B | 421.80% | |
| 78 | SPRBSPRUCE BIOSCIENCES INC | 2,046,958 | $22.9B | 407.59% | |
| 79 | ALECALECTOR INC | 1,055,192 | $22.0B | 390.43% | |
| 80 | TILINSTIL BIO INC | 1,115,739 | $21.6B | 382.90% | |
| 81 | —MONTES ARCHIMEDES ACQUISITIO | 2,000,000 | $21.3B | 378.71% | |
| 82 | PRNPROFOUND MED CORP | 1,297,797 | $21.2B | 377.14% | |
| 83 | NVRO 2.75 04/01/25NEVRO CORP | 12,000,000 | $20.9B | 370.59% | |
| 84 | OMGBPOUTSET MED INC | 400,622 | $20.0B | 355.67% | |
| 85 | PHVSPHARVARIS N V | 1,032,757 | $19.2B | 341.76% | |
| 86 | DAWNDAY ONE BIOPHARMACEUTICALS I | 818,980 | $18.6B | 331.25% | |
| 87 | RJR1STEREOTAXIS INC | 1,843,000 | $17.8B | 315.60% | |
| 88 | JANXJANUX THERAPEUTICS INC | 700,000 | $17.5B | 310.23% | |
| 89 | QSIQUANTUM SI INC | 1,400,000 | $17.2B | 304.88% | |
| 90 | DYNDYNE THERAPEUTICS INC | 787,000 | $16.6B | 294.12% | |
| 91 | AVTEAEROVATE THERAPEUTICS INC | 714,285 | $16.3B | 289.66% | |
| 92 | —PTC THERAPEUTICS INC | 14,527,000 | $15.6B | 276.36% | |
| 93 | —BLUEBIRD BIO INC | 480,300 | $15.4B | 272.84% | |
| 94 | CMRXEURCHIMERIX INC | 1,816,221 | $14.5B | 258.10% | |
| 95 | IMCRIMMUNOCORE HLDGS PLC | 360,966 | $14.1B | 250.39% | |
| 96 | —MEDAVAIL HOLDINGS INC | 1,142,552 | $14.0B | 248.61% | |
| 97 | RNAAVIDITY BIOSCIENCES INC | 560,132 | $13.8B | 245.86% | |
| 98 | BVSBIOVENTUS INC | 778,567 | $13.7B | 243.41% | |
| 99 | PRVAPRIVIA HEALTH GROUP INC | 300,000 | $13.3B | 236.44% | |
| 100 | AERIEURAERIE PHARMACEUTICALS INC | 825,937 | $13.2B | 234.88% |
Page 1 of 2Next